In the stem cell world some corporate names end up being very similar with the latest example being several companies with the name “BioLife.” Get a BioLife…name I guess BioLife is a catchy term. You’ve got life and biology in there in one name. Let’s deconstruct what’s going on out there with this corporate name. …
Perspectives on BioLife: one name, distinct companies Read More »
I remember seeing a cowboy-type TV show when I was a little kid where a guy pulled into town not slinging guns but selling snake oil. He stood right up on his wagon and started pitching the wonders of what he was selling. He had some buyers pretty quick. Eventually, someone like a sheriff or …
Snake oil history from century old elixirs to fake stem cells Read More »
One of the most common questions I’ve gotten over the last decade is, “how much does stem cell therapy cost?” They actually seem most often to want to know more specifically how much it should cost. To try to authoritatively answer this now in 2023 we need data from the present and past along with expert …
This was an unusual week in that three papers in a sense collided together related to embryo production and growth, raising new research possibilities but also serious ethical questions. New research: what is an embryo & what is not? The first two Nature papers reported generating the most realistic models of human embryos from scratch …
Weekly reads: embryo pubs stir things up, organoids crying, & more Read More »
What might be most surprising about this week’s recommended stem cell research reads is there’s nothing about COVID-19 in here. There are, however, some really great papers. And we can expect more developments on the cellular medicine for COVID-19 front coming soon. Before I jump into the reads, if you haven’t already check out our …
Weekly stem cell research reads: BAF, Polycomb, Fertility, More Read More »
The title of a new article in Stem Cells and Development may seem audacious to those unfamiliar with the plight of the northern white rhino and the promise of induced pluripotent stem cells. But “Rewinding Extinction in the Northern White Rhinoceros” may turn out to be accurate for what a genetically diverse stem cell bank …
What should we make of clinics like the Lung Health Institute? These clinics sell unproven stem cell or regenerative therapies for lung disease. Overall, I’m extremely skeptical. I don’t believe it’s worth the cost. There are also going to be potentially serious health risks. Lung disease is a broad category including COPD, emphysema, pulmonary fibrosis, …
Fact check: Lung Health Institute & cell therapies for lung disease Read More »
Stem cell stocks, meaning cellular therapy biotech companies, face many challenges, but their clinical research is crucial. Stem cell biotechs These biotechs have ups and downs, sometimes at the same time. This is kind of the standard of “life” as any biotech company. It is definitely the case in the volatile stem cell and cell …
24 cell therapy & stem cell stocks I’m following Read More »
I confess that I’m old enough to remember when the acronym MSC stood unambiguously for “mesenchymal stem cells”, but should it refer to a broader term like “mesenchymal cells”? The field has moved in that direction. I think that’s the best way to go too and I’ll explain why. The goal of today’s post is …
Mesenchymal cells or MSCs: definition, clinical potential, challenges Read More »
Science must go on and so must stem cell meetings 2021 with all those great conferences out there, but this year it’s going to be different, right? Every year I put up a continually-updated list of stem cell meetings and conferences. I’ve got my 2021 even if most of what’s out there is going to …
Hub of Regenerative Medicine & Stem Cell Meetings 2021 Read More »